Page last updated: 2024-09-02

fr 139317 and Pituitary Neoplasms

fr 139317 has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiou, WJ; Dixon, DB; Opgenorth, TJ; Wu-Wong, JR	1

Other Studies

1 other study(ies) available for fr 139317 and Pituitary Neoplasms

Article	Year
Dissociation characteristics of endothelin ETA receptor agonists and antagonists. Journal of cardiovascular pharmacology, 1995, Volume: 26 Suppl 3 Topics: Amino Acid Sequence; Animals; Azepines; Endothelin Receptor Antagonists; Endothelins; Indoles; Molecular Sequence Data; Peptides, Cyclic; Pituitary Neoplasms; Pyrimidines; Rats; Receptor, Endothelin A; Receptors, Endothelin; Sulfonamides; Tumor Cells, Cultured	1995

Article

Year

Dissociation characteristics of endothelin ETA receptor agonists and antagonists.

Journal of cardiovascular pharmacology, 1995, Volume: 26 Suppl 3

Topics: Amino Acid Sequence; Animals; Azepines; Endothelin Receptor Antagonists; Endothelins; Indoles; Molecular Sequence Data; Peptides, Cyclic; Pituitary Neoplasms; Pyrimidines; Rats; Receptor, Endothelin A; Receptors, Endothelin; Sulfonamides; Tumor Cells, Cultured

1995